Meeder Asset Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-52
Closed -$2.09K 889
2025
Q1
$2.09K Sell
52
-24
-32% -$965 ﹤0.01% 866
2024
Q4
$3.58K Buy
+76
New +$3.58K ﹤0.01% 865
2024
Q3
Sell
-43
Closed -$2.33K 863
2024
Q2
$2.33K Buy
43
+8
+23% +$433 ﹤0.01% 838
2024
Q1
$2.45K Buy
+35
New +$2.45K ﹤0.01% 708
2022
Q4
Sell
-263
Closed -$13K 1070
2022
Q3
$13K Sell
263
-6
-2% -$297 ﹤0.01% 1228
2022
Q2
$11K Buy
269
+61
+29% +$2.49K ﹤0.01% 1334
2022
Q1
$8K Sell
208
-6
-3% -$231 ﹤0.01% 1623
2021
Q4
$10K Buy
214
+5
+2% +$234 ﹤0.01% 754
2021
Q3
$7K Buy
209
+17
+9% +$569 ﹤0.01% 1792
2021
Q2
$4K Buy
192
+97
+102% +$2.02K ﹤0.01% 2005
2021
Q1
$2K Hold
95
﹤0.01% 2065
2020
Q4
$2K Buy
95
+13
+16% +$274 ﹤0.01% 1465
2020
Q3
$2K Hold
82
﹤0.01% 1822
2020
Q2
$2K Sell
82
-733
-90% -$17.9K ﹤0.01% 1755
2020
Q1
$9K Buy
+815
New +$9K ﹤0.01% 1550
2019
Q4
Sell
-2,652
Closed -$31K 2286
2019
Q3
$31K Sell
2,652
-7,342
-73% -$85.8K ﹤0.01% 1171
2019
Q2
$112K Buy
9,994
+8,011
+404% +$89.8K 0.01% 728
2019
Q1
$16K Buy
1,983
+1,370
+223% +$11.1K ﹤0.01% 1128
2018
Q4
$4K Sell
613
-338
-36% -$2.21K ﹤0.01% 1458
2018
Q3
$9K Buy
+951
New +$9K ﹤0.01% 1182
2018
Q1
Sell
-479
Closed -$4K 1599
2017
Q4
$4K Buy
479
+53
+12% +$443 ﹤0.01% 1353
2017
Q3
$6K Sell
426
-112
-21% -$1.58K ﹤0.01% 1200
2017
Q2
$7K Buy
538
+272
+102% +$3.54K ﹤0.01% 1086
2017
Q1
$3K Hold
266
﹤0.01% 1248
2016
Q4
$3K Buy
+266
New +$3K ﹤0.01% 901